Background In recent years, scientific knowledge pertaining to the rare ORPHAN
polyglandular autoimmune syndrome (registered code ORPHA 282196) has accumulated …

Purpose Polyglandular autoimmune syndromes (PAS) are complex, heterogeneous
disorders in which various autoimmune diseases can occur, affecting both endocrine and …

Polyglandular autoimmune syndromes (PAS) are rare polyendocrinopathies characterized
by the failure of several endocrine glands as well as nonendocrine organs, caused by an …

Context This mini-review offers an update on the rare autoimmune polyendocrinopathy (AP)
syndrome with a synopsis of recent developments. Design and Results Systematic search …

Autoimmune polyglandular diseases (APD) are defined as the presence of two autoimmune–
induced endocrine failures. With respect to the significant morbidity and potential mortality of …

Autoimmune Polyendocrine Syndromes (APS) were initially defined as a multiple endocrine
gland insufficiency associated to an autoimmune disease in a patient. Neufeld & Blizzard …

Autoimmune polyglandular syndromes originally defined by Blizzard, Maclaren and Neufeld
were classified into three constellations based on the clinical clustering of the various …

The autoimmune polyglandular syndromes (APSs) are recognizable patterns of coexistent
autoimmune endocrine disorders (eg, immunoendocrinopathies). Nonendocrine …

Abstract Type 1 diabetes (T1D) is an autoimmune disorder caused by inflammatory
destruction of the pancreatic tissue. The etiopathogenesis and characteristics of the …

Dysfunction of multiple endocrine glands may develop as the result of hypopituitarism,
various infiltrative disorders, or an organ-specific autoimmune mechanism. When …